Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The International Journal of Biological Markers|October 1, 1988
Changes in receptor status after treatment with tamoxifen in endometrial cancerS Oriana, F Raspagliesi, P G Duca, et al.
Oncology|May 1, 1994
Goserelin in premenopausal advanced breast cancer: clinical and endocrine evaluation of responsive patientsE Bajetta, N Zilembo, R Buzzoni, et al.
Tumori|April 30, 1984
Hormonal and receptor status in postmenopausal women with endometrial carcinoma before and after treatment with tamoxifenL Luciani, S Oriana, G Spatti, et al.
British Journal of Cancer|July 17, 2003
Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifenD Coradini, E Biganzoli, C Pellizzaro, et al.
British Journal of Cancer|May 1, 1994
The intramuscular administration of granulocyte colony-stimulating factor as an adjunct to chemotherapy in pretreated ovarian cancer patients: an Italian Trials in Medical Oncology (ITMO) Group pilot studyA Di Leo, E Bajetta, F Nolè, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosisA Di Leo, E Bajetta, L Biganzoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Time-dependent relevance of steroid receptors in breast cancerD Coradini, M G Daidone, P Boracchi, et al.
Tumori|December 31, 1994
An intensive treatment with mitoxantrone and ifosfamide in second-line therapy of epithelial ovarian cancerA D Leo, L Biganzoli, S Bohm, et al.
Oncology|August 26, 1999
Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinomaS Böhm, S Oriana, G Spatti, et al.
Cancer Research|February 15, 1996
A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinomaS C Righetti, G Della Torre, S Pilotti, et al.
Pageof 4